BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
10 hedge funds and large institutions have $1.58M invested in BriaCell Therapeutics Corp Warrant in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
67% more funds holding
Funds holding: 6 → 10 (+4)
33% more capital invested
Capital invested by funds: $1.19M → $1.58M (+$392K)
30.13% less ownership
Funds ownership: 144.15% → 114.02% (-30%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$13.4K |
| 2 |
VF
Virtu Financial
New York
|
+$13K |
| 3 |
Jane Street
New York
|
+$12.7K |
| 4 |
IP
Intellectus Partners
San Francisco,
California
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$363K |
| 2 |
AC
Armistice Capital
New York
|
-$56.8K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$34.2K |
| 4 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $675K | -$56.8K | -45,536 | -11% |
|
|
ACM
2
Altium Capital Management
New York
| $377K | -$363K | -290,460 | -58% |
|
|
M
3
Murchinson
Toronto,
Ontario, Canada
| $180K | +$125K | +100,000 | New |
|
|
RAM
4
Redmond Asset Management
Henrico,
Virginia
| $135K | – | – | – |
|
|
ZCA
5
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $81K | – | – | – |
|
|
WAM
6
Warberg Asset Management
Winnetka,
Illinois
| $58K | -$34.2K | -27,400 | -46% |
|
|
VF
7
Virtu Financial
New York
| $19K | +$13K | +10,445 | New |
|
|
8
Morgan Stanley
New York
| $19K | +$13.4K | +10,752 | New |
|
|
IP
9
Intellectus Partners
San Francisco,
California
| $18K | +$12.5K | +10,000 | New |
|
|
10
Jane Street
New York
| $18K | +$12.7K | +10,181 | New |
|
|
KJHP
11
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| – | -$11K | -10,000 | Closed |
|
BCTXW Hedge Fund Activity: Q2 2021 in Review
10 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q2 2021, worth a combined $1.58M — up 33% from $1.19M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BCTXW positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $13.4K. The largest seller was Altium Capital Management, cutting an estimated $363K.
- 10 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q2 2021, up from 6 in Q1 2021.
- Funds reported $1.58M of BriaCell Therapeutics Corp Warrant stock for Q2 2021, up 33% quarter-over-quarter.
- 5 funds opened new BriaCell Therapeutics Corp Warrant positions in Q2 2021 and 1 closed out, a net change of +4 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q2 2021 was Morgan Stanley, an estimated $13.4K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q2 2021 was Altium Capital Management, an estimated $363K sold.
Based on aggregated 13F filings for Q2 2021.